MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
DN4 (Douleur Neuropathique - Neuropathic Pain) PDF Print E-mail

Developed by:
Didier Bouhassira (France)

Objective:
To detect neuropathic pain

Copyright:
DN4© 2005. Bouhassira D. All rights reserved.

Reference publication:
Bouhassira D, Attal N, Alchaar H, BOUREAU F, BROCHET B, Bruxelle J et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnosis questionnaire (DN4). Pain 2005; 114(1-2):29-36

Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.

2. Access fees:

carre6 Author's royalty fees:

  1. In commercial clinical studies: 500 €* per study and per existing language-version requested.
  2. In commercial epidemiologic / observational / marketing studies: 500 €* per study and per existing language-version requested + the following administrative fee:


    · Up to 1000 administrations/reproductions: 2 €* per administration/ reproduction;
    · Between 1001 and 2500 administrations/reproductions: 1.80 €* per administration/ reproduction;
    · From 2500 administrations/reproductions: 1.60 €* per administration/ reproduction.

   3.  In any academic research and clinical practice: free

Other specific conditions requested by the Author are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 300 €* per study + 50 €* per language version
- In commercial studies (3) involving "for-profit" organizations: 600 €* per study + 150 €* per language 
   version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).

Review copy:

English version available for review purpose only. Please click here to access.

Contact information:

MAPI Research Trust
Christelle BERNE

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on the DN4 on PROQOLID


[ BACK ]
 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org